Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II…

Overview of attention for article published in Trials, June 2020

Altmetric Badge

Mentioned by

twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 746 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,326 followers.

Otra terapia para el COVID para valorar por el juez. Esto es un plan de un tal Pérez, que es casi una rata, para copar el mercado farmacéutico de tratamientos del COVID. OJO!! No te fíes. https://t.co/coerGxmnoF

15 Aug 2021

Reply Repost Favourite

Nasal Eos Studies Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). https://t.co/EZHFYCIJ0S

14 Jun 2020

Reply Repost Favourite

Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). by Ye Q, Wang H, Xia X, Zhou C, Liu Z, Xia ZE, Zha…

14 Jun 2020

Reply Repost Favourite